Shares of Regeneron are up 2 percent after President Donald Trump credited the company’s experimental antibody drug treatment with aiding his COVID-19 recovery.
Regeneron CEO is a member of Trump's golf club
Oct 8, 2020
Shares of Regeneron are up 2 percent after President Donald Trump credited the company’s experimental antibody drug treatment with aiding his COVID-19 recovery.